CDX2 and hereditary elliptocytosis: Compared to the different CDX2 expression groups, the central HE-based morphologic parameters generally showed stronger survival discrimination than the CDX2-expression groups in the overall cohort and in Microsatellite subcohorts as well as UICC Stage 2/3 subgroups [8].